Figure 6.

Effect of resveratrol (RSV; 20 mg/kg b.wt) and/or iron oxide nanoparticles (Fe₂O₃-NPs 3.5 or 7 mg/kg b.wt) administration for eight weeks on mRNA expression of (A) 3 beta-Hydroxysteroid dehydrogenase (3β-HSD), (B) 17-beta hydroxysteroid dehydrogenase (17β-HSD), and (C) Nuclear Receptor Subfamily 5 Group A Member 1 (Nr5A1) in the testicular tissues of male rats. Data expressed as mean ± SD, n = 9 for each group. Different letters (a, b, c, and d) on columns indicate statistically significant differences at p < 0.05 between the different experimental groups.